Sable
London, GB · Founded 2023 · 15 employees on LinkedIn · 3 known investors
Find your way into Sable
Sable Bio develops AI-powered tools for researchers to evaluate drug safety and accelerate the development of safe and effective medicines. The company combines engineering with biological expertise to support pharmaceutical researchers in making better decisions.
Investors · 3
Competitors · 2
by search overlap
Sab5 shared keywordsSAB BIO is a clinical-stage biopharmaceutical company developing multi-specific human immunoglobulin G (hIgG) therapies to treat and prevent immune and autoimmune disorders, using genetically engineered transchromosomic cattle to produce therapeutic candidates. The company has advanced its lead candidate SAB-142 for Type 1 Diabetes into Phase 2b clinical trials.
Sana Biotechnology3 shared keywordsSana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.
Companies competing with Sable for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Sable do?
- Sable Bio develops AI-powered tools for researchers to evaluate drug safety and accelerate the development of safe and effective medicines. The company combines engineering with biological expertise to support pharmaceutical researchers in making better decisions.
- Who are Sable's investors?
- Sable's investors include Seedcamp, Episode1, MMC Ventures.
- Where is Sable headquartered?
- Sable is headquartered in London, GB.